Karim Bitar Sells 436,692 Shares of ConvaTec Group PLC (LON:CTEC) Stock

ConvaTec Group PLC (LON:CTECGet Free Report) insider Karim Bitar sold 436,692 shares of ConvaTec Group stock in a transaction on Monday, March 17th. The shares were sold at an average price of GBX 256 ($3.33), for a total transaction of £1,117,931.52 ($1,454,314.45).

Karim Bitar also recently made the following trade(s):

  • On Friday, March 14th, Karim Bitar sold 132,253 shares of ConvaTec Group stock. The shares were sold at an average price of GBX 256 ($3.33), for a total transaction of £338,567.68 ($440,441.89).

ConvaTec Group Stock Down 1.0 %

Shares of CTEC opened at GBX 257.20 ($3.35) on Thursday. The stock has a 50 day moving average price of GBX 247.07 and a 200 day moving average price of GBX 234.67. ConvaTec Group PLC has a one year low of GBX 211.80 ($2.76) and a one year high of GBX 295.20 ($3.84). The company has a debt-to-equity ratio of 85.32, a quick ratio of 0.96 and a current ratio of 2.26. The stock has a market capitalization of £6.54 billion, a price-to-earnings ratio of 43.31, a PEG ratio of 0.93 and a beta of 0.64.

ConvaTec Group Increases Dividend

The firm also recently announced a dividend, which will be paid on Thursday, May 29th. Stockholders of record on Thursday, April 17th will be issued a dividend of $0.05 per share. This is a positive change from ConvaTec Group’s previous dividend of $0.02. The ex-dividend date of this dividend is Thursday, April 17th. This represents a dividend yield of 1.36%. ConvaTec Group’s dividend payout ratio is presently 84.20%.

Wall Street Analyst Weigh In

Separately, Berenberg Bank restated a “buy” rating and set a GBX 310 ($4.03) price target on shares of ConvaTec Group in a research report on Wednesday, March 5th.

Read Our Latest Analysis on CTEC

ConvaTec Group Company Profile

(Get Free Report)

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.

Read More

Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.